On December 7, 2022 Targovax ASA reported that members of its executive management team are invited to present at following upcoming conferences (Press release, Targovax, DEC 7, 2022, View Source [SID1234624874]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

7th Annual Oncolytic Virotherapy Summit, Boston, USA
Date: 7 December 2022
Presenter: Erik Digman Wiklund, CEO
Time: 12:00 EDT / 18:00 CET

DNB Nordic Healthcare Conference, Oslo, Norway
Date: 15 December 2022
Presenter: Erik Digman Wiklund, CEO
Time: 15:10 CET

Biotech Showcase, J.P. Morgan Healthcare week
Date: 9-12 January 2023
Attending: Erik Digman Wiklund, CEO, Lubor Gaal, CFO

***

For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: [email protected]

Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: [email protected]

Media enquires:
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47 9300 1773
Email: [email protected]